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Abstract
Background: The 14-3-3 (YWHA) proteins are a highly conserved, ubiquitously expressed family of proteins. Seven
mammalian isoforms of 14-3-3 are known (b, g, ε, ζ, h, τ and, s). These proteins associate with many intracellular
proteins involved in a variety of cellular processes including regulation of the cell cycle, metabolism and protein
trafficking. We are particularly interested in the role of 14-3-3 in meiosis in mammalian eggs and the role 14-3-3
proteins may play in ovarian function. Therefore, we examined the expression of 14-3-3 proteins in mouse oocyte
and egg extracts by Western blotting after polyacrylamide gel electrophoresis, viewed fixed cells by indirect
immunofluorescence, and examined mouse ovarian cells by immunohistochemical staining to study the expression
of the different 14-3-3 isoforms.
Results: We have determined that all of the mammalian 14-3-3 isoforms are expressed in mouse eggs and ovarian
follicular cells including oocytes. Immunofluorescence confocal microscopy of isolated oocytes and eggs confirmed
the presence of all of the isoforms with characteristic differences in some of their intracellular localizations. For
example, some isoforms (b, ε, g, and ζ) are expressed more prominently in peripheral cytoplasm compared to the
germinal vesicles in oocytes, but are uniformly dispersed within eggs. On the other hand, 14-3-3h is diffusely
dispersed in the oocyte, but attains a uniform punctate distribution in the egg with marked accumulation in the
region of the meiotic spindle apparatus. Immunohistochemical staining detected all isoforms within ovarian
follicles, with some similarities as well as notable differences in relative amounts, localizations and patterns of
expression in multiple cell types at various stages of follicular development.
Conclusions: We found that mouse oocytes, eggs and follicular cells within the ovary express all seven isoforms of
the 14-3-3 protein. Examination of the differential expression of these 14-3-3 isoforms in female germ cells and
ovarian follicles provides the foundation for further investigating 14-3-3 isoform-specific interactions with key
proteins involved in ovarian development, meiosis and oocyte maturation. This will lead to a better understanding
of the individual functional roles of the 14-3-3 protein isoforms in mammalian oogenesis and female reproductive
development.
Background
Members of the 14-3-3 family are key proteins in a
number of intracellular events, particularly those invol-
ving phosphorylation-dependent switching. The proteins
bind to a diverse set of target proteins and alter cellular
function by binding to and causing conformational
changes in target proteins or modifying target protein
interactions with other proteins. Of particular interest,
14-3-3 appears to be central to several aspects of verte-
brate development and cell cycle regulation, including
meiosis in amphibians [1,2]; however, the functions of
14-3-3 in mammalian reproductive organs and in
gametes have not been completely elucidated. There is
also interest in understanding the role of 14-3-3 pro-
teins in the regulation of oogenesis and the cell cycle
during oocyte maturation and in early development. In
addition, 14-3-3 proteins, by their participation in the
regulation of the cell cycle, apoptosis, and tumor sup-
pression, are important in normal growth and develop-
ment as well as in cancer [3].
The 14-3-3 proteins are a family of highly conserved,
homologous proteins encoded by separate genes. The
name for the protein family is tyrosine 3-monooxygenase/
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tryptophan 5-monooxygenase activation protein family
(YWHA). The 14-3-3 name is still commonly used. There
are seven mammalian isoforms of 14-3-3 encoded by
seven different genes: b (Ywhab), g (Ywhag), ε (Ywhae), ζ,
(Ywhaz), h (Ywhah), τ (Ywhaq) and s (Sfn) [4]. The 14-3-
3 proteins exist as homo- or hetero-dimers [5,6]. It is
known that different 14-3-3 isoforms can interact with the
same ligand and so are somewhat interchangeable.
Although different isoforms of 14-3-3 may bind the same
protein, there are some indications that homodimers of
different types or even heterodimers of 14-3-3 may have
different roles in the regulation or sequestering of proteins
[7-9].
The roles of 14-3-3 proteins in the ovary may parallel
function in other tissues. For example, 14-3-3s is
expressed at lower levels in cancerous cells in a number
of tissues including adenocarcinomas of the ovary [3,10].
However, specific descriptions of the roles of 14-3-3
proteins in the ovary are few. In female mammals, meio-
sis is initiated prenatally and oocytes remain arrested in
an immature state at late prophase of the first meiotic
division for long periods of time. This arrest is released
as a result of the pre-ovulatory surge in luteinizing hor-
mone and oocytes enter the first meiotic division cycle
and arrest at metaphase II of meiosis to form the
mature egg. It has been suggested that, in mammalian
oocytes, 14-3-3 binds to and regulates the cell cycle con-
trol protein CDC25B phosphatase (cell division cycle 25
homolog B), as it does in amphibian oocytes, to hold
the cell in prophase arrest [11]. In another case, we
have shown that 14-3-3 interacts with phosphorylated
PADI6, a key maternal effect protein, in mature eggs,
but not with unphosphorylated PADI6 in immature
oocytes [12]. While such interactions have been exam-
ined in part, more information about specific isoforms is
needed. It is also clear that many more cellular pro-
cesses in the ovary and in the female gametes might be
regulated by 14-3-3. As a pre-requisite for understand-
ing the role(s) of 14-3-3 in mammalian female repro-
ductive development and oocyte maturation, we must
understand which cell types express which individual
isoforms. The present study explores the various iso-
forms of this protein and the characteristic patterns of
expression in immature oocytes, mature eggs and in the
various developmental stages of ovarian follicles in the
adult mouse.
Results and discussion
14-3-3 proteins in oocytes and eggs
Immature, prophase I-arrested mouse oocytes and
mature, metaphase II-arrested eggs appear to express all
seven 14-3-3 isoforms. Three approaches were used to
determine if these cells contained each of the isoforms
of 14-3-3. We examined the proteins in oocyte and egg
extracts by Western blotting after polyacrylamide gel
electrophoresis, viewed fixed cells by indirect immuno-
fluorescence, and examined oocytes also by immunohis-
tochemical staining of cells within ovarian sections. All
three approaches relied on a panel of antibodies that
has been shown to be specific for the various 14-3-3 iso-
forms. Martin and his colleagues [13,14] described the
generation of the panel of antibodies and used them to
detect the major brain isoforms of 14-3-3. They con-
firmed, by several methods, the high specificity of each
of these antibodies, which is due to the fact that the epi-
tope for each antibody is mainly in the N-acetylated
amino terminus of the different peptide immunogens.
The panel of 14-3-3 isoform-specific antibodies was also
used to identify the isoforms of 14-3-3 proteins
expressed in human dermal and epidermal layers [15]
and in adrenal chromaffin cells [16].
Presence and relative abundance of 14-3-3 isoforms in
oocytes and eggs determined by Western blotting
Western blots of extracts from 200 oocytes or 200 eggs
indicate the presence of six of the seven isoforms (Fig-
ure 1). These six isoforms of 14-3-3 were also detected
in ovarian protein extracts by Western blotting. We
could not detect 14-3-3s by Western blotting; however,
it was identified in oocytes and eggs by immunocyto-
chemistry and in ovarian follicle cells, including oocytes,
by immunohistochemical staining. The inability to
Figure 1 Immunoblots identifying 14-3-3 isoforms in extracts
from mouse oocytes, eggs and ovaries. Proteins from cell lysates
were separated by electrophoresis under reducing conditions,
transferred to membranes and probed with antibodies directed
against the 14-3-3 isoforms indicated. Each isoform shown was
detected in lysates of 200 oocytes or 200 eggs. Protein extracts of
ovaries and brain from adult mice are included for comparison. The
14-3-3 protein is approximately 30 kDa.
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detect 14-3-3s in Western blots may be due to the
unsuitability of this antibody in recognizing a denatured
antigen in our Western blotting procedure.
We were interested to determine the relative amounts
of the 14-3-3 isoforms in immature oocytes and in
mature eggs. Quantitative changes in total amount of
specific 14-3-3 isoforms could provide insights into the
regulation of oocyte maturation or other aspects of
development. Such a comparison is possible as each
experiment examines proteins from the same number of
oocytes or eggs (200 cells) loaded onto two lanes of gel
and the proteins are simultaneously transferred to a
membrane and probed with the same antibody and
Western blotting reagents. The qualitative comparison
of one such experiment is shown in Figure 1. We
repeated this experiment two additional times and made
a relative comparison for each isoform (Figure 2). The
proteins 14-3-3b, 14-3-3ε, 14-3-3h, and 14-3-3ζ appear
in lesser amounts in mature eggs than in immature
oocytes. For example, a marked decrease in the 14-3-3b
isoform after maturation of oocytes into eggs is
observed. On the contrary, amounts of 14-3-3g and 14-
3-3τ were found to increase following oocyte
maturation. It should be noted that, in these experi-
ments, it is only possible to make quantitative compari-
sons for a single isoform and not between different
isoforms as the isoform-specific antibodies may have dif-
ferent affinities and therefore different intensities on a
Western blot.
Expression of 14-3-3 isoforms in oocytes and eggs
determined by immunofluorescence
Immunofluorescence microscopy confirms the presence
of all seven 14-3-3 isoforms in oocytes and eggs (Figure
3). Oocytes and eggs were fixed in paraformaldehyde,
permeabilized with detergent and incubated with iso-
form-specific antibodies for 14-3-3, followed by applica-
tion of a fluorescently-labeled secondary antibody and
viewed by scanning confocal microscopy. The subcellu-
lar distributions of the isoforms were found to vary
from one isoform to another. For example, 14-3-3ε is
expressed uniformly throughout the oocyte with some
peripheral accumulation, and absent in the interior of
the egg cytoplasm (Figure 3E-F). 14-3-3τ is distributed
uniformly in oocytes and eggs, but is particularly absent
along the inner nuclear membrane of all oocytes
Figure 2 Comparison of the relative abundance of individual 14-3-3 isoforms in immature oocytes and mature eggs. The relative
abundance of each individual isoform is based on the integrated densities of bands obtained from immunoblots (see Methods). Three
experimental immunoblots were prepared for each of the six isoforms shown. In each experiment, for one of the isoforms, protein extracts from
200 oocytes and 200 eggs was analyzed after electrophoresis and immunoblotting on the same blot. For every blot, the density of the band for
oocyte extracts was normalized to 100% and the density of the band for eggs is given as a percent with regards to the normalized oocyte
value.
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examined (Figure 3I-J). Isoforms 14-3-3b, 14-3-3g and
14-3-3ζ exhibit a notable peripheral accumulation in
oocytes, with a uniform distribution in eggs (Figure 3A-
B,3C-D and 3G-H respectively). 14-3-3s is found to be
expressed in higher levels in nuclei of all oocytes stu-
died, as compared to their cytoplasm, where it is uni-
formly dispersed with some accumulation selectively
along one half of the cell (Figure 3K); however, the 14-
3-3s isoform shows a uniform distribution in eggs (Fig-
ure 3L). 14-3-3h is diffusely dispersed in oocyte with
lesser distribution in the germinal vesicle than in the
cytoplasm, but attains a uniform punctuate distribution
with prominent accumulation in the region of the meio-
tic spindle in all eggs observed (Figure 3M-N).
Control oocytes and eggs incubated in secondary anti-
body alone displayed little background fluorescence at
Figure 3 Representative immunofluorescence images of 14-3-3 isoforms in oocytes and eggs isolated from adult mice. (A, B) 14-3-3b.
(C, D) 14-3-3g. (E, F) 14-3-3ε. (G, H) 14-3-3ζ. (I, J) 14-3-3 τ. (K, L) 14-3-3s. (M, N) 14-3-3h. Confocal sections with regions of red fluorescence
indicating the corresponding isoforms studied (see Methods). The inset in N shows the same egg labeled blue with Hoechst DNA stain (non-
confocal image) and confirms that the darker areas in this region of the larger image are condensed metaphase II chromosomes. Control cells
were included for each isoform experiment and were imaged using the same confocal settings. Representative control oocytes and eggs are
shown in bright-field (O) and fluorescence (P). 14-3-3h accumulates, in part, in the meiotic spindle in eggs as shown by simultaneous labeling
with 14-3-3h (Q) and tubulin (R) antibodies. These sequential scans are merged (14-3-3h + tubulin) in (S). The scale bars represent 10 μm for all
images.
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the same laser intensities and confocal imaging settings
used for each immunofluorescence experiment (Figure
3O-P). No attempt was made to compare the relative
fluorescence intensity of a particular isoform in oocytes
or eggs with that of a different isoform, since the anti-
bodies detecting the isoforms were all different.
These experiments are the first to examine all of the
14-3-3 proteins in mouse oocytes and eggs. Previous
work suggested that multiple isoforms could be present,
for example an examination of the maternal component
of the zygotic polysomal mRNA population in mouse
eggs and one-cell embryos revealed an increase in
maternal mRNAs for 14-3-3b, 14-3-3g, 14-3-3ζ, 14-3-3h
and 14-3-3τ. The other isoform mRNAs were not exam-
ined in this paper [17].
It has been suggested that, in mammalian oocytes, 14-
3-3 binds to and regulates the cell cycle control protein
CDC25B phosphatase [11]. There is good evidence from
studies of frog oocytes that 14-3-3 protein may act to
hold the oocyte in prophase I arrest by binding to and
localizing phosphorylated CDC25B in the cytoplasm [18].
Following the induction of oocyte maturation, CDC25B
is thought to be dephosphorylated and released from 14-
3-3, allowing it to participate in the activation of MPF
which leads to germinal vesicle breakdown and the
resumption of meiosis. It is not known which of the
seven isoforms in the mammalian oocyte might be inter-
acting with CDC25B; we have shown here that all are
present in oocytes. The interaction of 14-3-3 with the
cell cycle control protein CDC25B has been examined in
mammalian somatic cells. There is strong evidence to
indicate that 14-3-3b, 14-3-3ε, and 14-3-3s bind to
CDC25B and that 14-3-3b is responsible for sequestering
CDC25B in the cytoplasm [11,19]. Future experiments
will be needed to determine if the other 14-3-3 isoforms,
which we have now found to be present as well in mouse
oocytes, also interact with CDC25B and whether they are
involved in the regulation of oocyte maturation.
Prominent localization of 14-3-3s in the nuclei of
oocytes (Figure 3I) is consistent with the observations
that 14-3-3 proteins can shuttle through the nuclear
membrane, but is in contrast with some observations in
somatic cells in which it was noted that 14-3-3s is more
abundant in the cytoplasm than in the nucleus, while
14-3-3ζ is more abundant in the nucleus as compared
to the cytoplasm [20].
Localization of 14-3-3h in the meiotic spindle (Figure
3N, Q, R and 3S) suggests a role for 14-3-3 in spindle
assembly or cell cycle control. This is the first evidence
for the localization of a specific 14-3-3 isoform in the
metaphase II spindle of mouse eggs. It has been
reported that 14-3-3ε and 14-3-3g localize in the centro-
some and mitotic spindle of some mouse somatic cells
lines [21]. Additional functional studies are needed to
determine if 14-3-3h plays a role in the formation or
regulation of the meiotic spindle or chromosome
separation in mammalian oocytes.
Expression of 14-3-3 isoforms in ovarian cells determined
by immunohistochemistry
As work on the role of 14-3-3 in ovarian development,
oogenesis and cancer proceeds, it will be valuable to
know which 14-3-3 isoforms are present and/or abun-
dant in both the somatic cells and the germ cells within
the ovary. We examined mouse ovarian follicular sec-
tions by immunohistochemical staining using isoform-
specific antibodies and the Avidin: Biotinylated enzyme
Complex (ABC) technique. The sections contained ovar-
ian follicles at all stages of development. The ABC
method relies on the high affinity of avidin for biotin
and the method is known to produce minimal back-
ground staining in the absence of primary antibody
[22,23]. Regions stained brown indicate presence of the
14-3-3 isoforms in contrast with regions counterstained
blue. Again it is not possible to determine the relative
amounts of distribution of a particular isoform in cells
compared to other isoforms as the antibodies are differ-
ent; nevertheless for a given isoform, variations in the
intensities of staining indicate differences in relative
amounts of expression among different cells in follicles
and surrounding tissue.
We show here by immunohistochemistry that all
seven isoforms of 14-3-3 protein were detected in cells
of the ovary. Follicles at various stages of development
exhibit some common features of expression of the iso-
forms. All isoforms of 14-3-3 were detected, to varying
extents, in the oocyte and cumulus cells surrounding
the oocyte, mural granulosa cells, theca interna and
theca externa of all follicular stages examined, as well as
in cells of the corpus luteum (Figures 4, 5, 6, 7, 8, 9 and
10). In each of the follicular stages studied, all the iso-
forms appear to be expressed in the cytoplasm of the
oocytes and to some extent in the corresponding germ-
inal vesicles (Figures 4, 5, 6, 7, 8,9 and 10). For all iso-
forms, staining appeared more intense in the cytoplasm
than in the nuclei of somatic cells in granulosa and
theca layers as well as in cells of corpora lutea (Figures
4, 5, 6, 7, 8,9 and 10). Cells within corpora lutea were
also found to have relatively higher amounts of expres-
sion of all of the isoforms as compared to surrounding
interstitial cells F in (Figures 4, 5, 6, 7, 8,9 and 10). The
isoform 14-3-3τ appears to be expressed at lower levels
in somatic cells when compared to oocytes (Figure 9A-
E). Atretic follicles, characterized by intensely stained
pyknotic (apoptotic) and/or lytic cells, exhibit prominent
accumulation of all isoforms of 14-3-3 (Figure 11A-G).
While the specific activities of 14-3-3 proteins in ovar-
ian function are largely unknown, these proteins could
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Figure 4 Representative immunohistochemistry images of 14-3-3 b in the different stages of follicular development in ovarian
sections. Brown staining represents 14-3-3 b against regions counterstained blue with hematoxylin. (A) Primordial follicle. (B) Primary follicle. (C)
Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus luteum. White arrows indicate the primordial or primary
follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary follicles (C, green arrows), the more intense stain along the
zona pellucida of the oocyte (C, yellow arrow), and the more intense staining in cells lining the antral cavity (D and E, red arrows). The scale bars
represent 10 μm (A-C) or 100 μm (D-F).
Figure 5 Representative immunohistochemistry images of 14-3-3 g in the different stages of follicular development in ovarian
sections. (A) Primordial follicle. (B) Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus
luteum. White arrows indicate the primordial or primary follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary
follicles (C, green arrows) and the more intense staining in cells lining the antral cavity (D and E, red arrows). The scale bars represent 10 μm (A-
C) or 100 μm (D-F).
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Figure 6 Representative immunohistochemistry images of 14-3-3 ε in the different stages of follicular development in ovarian
sections. (A) Primordial follicle. (B) Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus
luteum. White arrows indicate the primordial or primary follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte (C, yellow arrow), and the more intense staining in cells
lining the antral cavity (E, red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F).
Figure 7 Representative immunohistochemistry images of 14-3-3 ζ in the different stages of follicular development in ovarian
sections. (A) Primordial follicle. (B) Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus
luteum. White arrows indicate the primordial or primary follicles in (A and B). Note the more intense staining in cells lining the antral cavity (E,
red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F).
De et al. BMC Research Notes 2012, 5:57
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Figure 8 Representative immunohistochemistry images of 14-3-3 h in the different stages of follicular development in ovarian
sections. (A) Primordial follicle. (B) Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus
luteum. White arrows indicate the primordial or primary follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary
follicles (C, green arrows) and the more intense staining in cells lining the antral cavity (E, red arrows). The scale bars represent 10 μm (A-C) or
100 μm (D-F).
Figure 9 Representative immunohistochemistry images of 14-3-3 τ in the different stages of follicular development in ovarian
sections. (A) Primordial follicle. (B) Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus
luteum. White arrows indicate the primordial or primary follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte (C, yellow arrow), and the more intense staining in cells
lining the antral cavity (E, red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F).
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play a significant role. For example, 14-3-3τ, shown to
be present in human granulosa cells, has been shown to
bind to the human follitropin (follicle stimulating hor-
mone, FSH) receptor suggesting a role for 14-3-3 pro-
teins in follitropin signaling in granulosa cells [24,25].
The reason for intense 14-3-3 staining in apoptotic cells
is not known. 14-3-3 is generally associated with anti-
apoptotic functions [26]. 14-3-3 proteins appear to be
involved in several ways in promoting cell survival, for
example 14-3-3 has been found to enhance the activity
of proteins with proliferative or survival roles, such as
members of the Raf family, while antagonizing the activ-
ity of proteins that promote cell death [3,27]. There is
some suggestion that 14-3-3s is associated with the sur-
vival of granulosa cells and inhibition of 14-3-3 interac-
tion with target proteins, without regard to isoform,
promotes apoptosis in these cells [28,29].
Several characteristic differences in expression of 14-
3-3 protein isoforms in different stages of follicular
development were observed by immunohistochemical
staining. Detection of 14-3-3b, 14-3-3g, 14-3-3ε, 14-3-
3τ and 14-3-3s in zonae pellucidae of oocytes by
immunohistochemical staining indicates secretion of
some 14-3-3 proteins into the zonae and perivitelline
space (Table 1; C in Figures 4, 6, 9 and 10). To exam-
ine this by another method, we isolated zona-intact
oocytes and viewed them by immunofluorescence.
Such immunocytochemical staining detected the same
isoforms along the membranes of the isolated oocytes
and within or along the zonae pellucidae of oocytes
(Figure 112B, D, F, L and N), indicating secretion of
those 14-3-3 isoforms by the oocyte or associated folli-
cle cells. Control oocytes processed for fluorescence
microscopy without the addition of primary antibody
showed no fluorescence above background (Figure
12O-P).
The function, if any, of extracellular 14-3-3 surround-
ing the oocyte is not yet known. We do not believe this
is an artifact of fixation since the appearance of the
extracellular 14-3-3 was found by two different methods
and the absence of staining for some isoforms argues
against nonspecific artifacts. We did not find extracellu-
lar 14-3-3 proteins associated with mature, ovulated
eggs, which also suggests that this is not an artifact
(data not shown). While the 14-3-3 proteins are gener-
ally known as intracellular proteins, some 14-3-3 pro-
teins are known to be secreted by somatic cells; for
example, it has been known for some time that 14-3-3
proteins are found in the cerebrospinal fluid [30] where
they may serve as markers for Creutzfeldt-Jakob disease.
Keratinocytes secrete 14-3-3s which induces expression
of matrix metalloproteinase 1 (MMP1 or collagenase) in
fibroblasts [31]. Three isoforms, 14-3-3 s, 14-3-3 g and
14-3-3ζ, are secreted by corneal epithelial cells and
Figure 10 Representative immunohistochemistry images of 14-3-3 s in the different stages of follicular development in ovarian
sections. (A) Primordial follicle. (B) Primary follicle. (C) Secondary follicle. (D) Early antral follicle. (E) Graafian (advanced antral) follicle. (F) Corpus
luteum. White arrows indicate the primordial or primary follicles in (A and B). Note the weaker staining in mural granulosa cells in secondary
follicles (C, green arrows), the more intense stain along the zona pellucida of the oocyte (C, yellow arrow), and the more intense staining in cells
lining the antral cavity (D and E, red arrows). The scale bars represent 10 μm (A-C) or 100 μm (D-F).
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ocular cell lines [32]. The14-3-3ζ protein is secreted by
certain tumor associated inflammatory cells [33].
Another notable difference in the distribution of 14-3-
3 isoforms in ovarian folliculogenesis is prominent lack
of expression 14-3-3b, 14-3-3g, 14-3-3ε, 14-3-3τ, 14-3-
3h and 14-3-3s in the peripheral mural granulosa cells,
as compared to other cells of secondary, early antral
and/or Graafian follicles (Table 1; C in Figures 4, 5 and
6 and 8, 9 and 10). At early antral stages, intense stain-
ing was noted for 14-3-3b, 14-3-3g and 14-3-3s in gran-
ulosa cells surrounding the antrum (Table 1; D in
Figures 1, 2 and 10). At the Graafian stage, all isoforms
appear to accumulate in these cells (Table 1; E in Fig-
ures 4, 5, 6, 7, 8, 9 and 10).
Conclusions
Seven isoforms of the protein 14-3-3 are expressed in
the female mouse germ cells and in cells of mouse ovar-
ian follicles at various stages of development. There are
characteristic differences in the relative amount and
distribution of 14-3-3 proteins in oocytes and eggs. Pro-
tein 14-3-3h, for example localizes, in part, to the meio-
tic spindle in eggs. A number of isoforms appear to be
extracellular and associated with the zona pellucida in
ovarian oocytes. The distribution of some 14-3-3 iso-
forms within cells of the ovary differs, for example with
peripheral mural granulosa cells expressing some iso-
forms and not others. All 14-3-3 isoforms appear to be
present in relatively greater amounts in cells lining the
antral cavity of Graafian follicles and in granulosa cells
of atretic follicles. These results will enable further
research investigating 14-3-3 interactions with other key
proteins involved in ovarian development and gamete
function.
Methods
Collection of Oocytes and Eggs and Preparation of
Ovarian Tissue Extracts
All mice used in the present experiments were housed
and used at Kent State University under an approved
Figure 11 Representative immunohistochemistry images of 14-3-3 protein isoforms in atretic follicles of adult mouse ovaries. (A) 14-3-
3 b. (B) 14-3-3 g. (C) 14-3-3 ε. (D) 14-3-3 ζ. (E) 14-3-3h. (F) 14-3-3 τ. (G) 14-3-3 s. All scale bars indicate 100 μm.
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Institutional Animal Care and Use Committee protocol
following the National Research Council’s publication
Guide for the Care and Use of Laboratory Animals.
Oocytes and eggs were collected as previously described
[12]. CD1 mice (2.5 months old) were injected with 7.5
IU eCG and, 44-48 h later, the ovaries were removed
and repeatedly punctured with a 26-gauge needle to
rupture follicles. Cumulus cell-enclosed oocytes were
isolated and the cumulus cells were removed by
repeated pipetting though a small-bore pipette. Fully-
grown oocytes with intact nuclei (germinal vesicles)
were cultured in MEM containing 0.1 mg/ml dibutyryl
cAMP to prevent spontaneous oocyte maturation.
Mature, metaphase II-arrested eggs were obtained from
mice 13-14 h following superovulation by injection of
7.5 IU hCG which was preceded by a priming injection
of 7.5 IU eCG injection 48 h earlier. The cumulus cells
were removed with 0.3 mg/ml hyaluronidase. Zonae pel-
lucidae from oocytes and eggs thus collected were
removed by a brief treatment in acid Tyrode’s solution
(0.14 M NaCl, 3 mM KCl, 1.6 mM CaCl2.2H2O, 0.5
mM MgCl2.6H2O, 5.5 mM glucose, and 0.1% PVA, pH
2.5). Cells were rinsed in MEM and prepared for use in
Western blot or immunocytochemistry as described
below.
SDS-PAGE, Western Blotting and Protein Analysis
14-3-3 isoforms were identified through multiple Wes-
tern blots (using standard Western blotting procedures),
each testing for one of the seven isoforms in protein
extracts. Oocytes and eggs were rinsed in MEM,
counted, and transferred to Tris-buffered saline (TBS;
25 mM Tris-HCl [pH 7.5] and 150 mM NaCl) contain-
ing 0.1% PVA. Cells were removed from the TBS, lysing
buffer was added, and the cell lysates were quick-frozen
in ethanol/dry ice and stored at -70°C until use. The
lysis buffer contained 10 mM Tris-HCl [pH 7.2], 1 mM
EDTA, 1 mM EGTA, 0.1% (v/v) b-mercaptoethanol, 1%
(v/v) Triton X-100, protease inhibitors (1 mM PMSF,
0.1 mM TPCK, 10 μM leupeptin, 1 μM pepstatin A, and
75 nM aprotinin), and phosphatase inhibitors (1 mM
Na3VO4, 100 nM calyculin A, 10 mM beta-glyceropho-
sphate, and 5 mM sodium pyrophosphate).
Proteins from the lysates of 200 oocytes or 200 eggs
were separated by SDS-PAGE using a 4% stacking, 12%
resolving polyacrylamide gel and electrophoretically
transferred to Immobilon-P PVDF membrane (Millipore
Corp.). The membranes were incubated in blocking buf-
fer (5% milk in TBS, 0.1% Tween-20) and then with pri-
mary antibodies overnight at 4°C, washed and incubated
with secondary antibody and imaged by chemilumines-
cence with an enhanced chemiluminescence kit accord-
ing to the manufacturer’s instructions (GE Healthcare
Life Sciences) using the Fujifilm LAS-3000 luminescent
image analyzer. Protein extracts of ovaries from adult
mice were included for comparison, loading identical
amounts of protein extract for all isoform immunoblots.
Brain extract, loaded with the same amount of protein
extract for each isoform, was used as a positive control
for all isoforms of 14-3-3 except 14-3-3s for which skin
Table 1 Characteristic differences in expression of 14-3-3 protein isoforms in the different stages of follicular
development as observed by immunohistochemical staining of adult mouse ovarian sections
Feature Isoform Stage of Ovarian Follicle
Secondary Early Antral Graafian
Expression
in zonae pellucidae
around
oocytes
14-3-3 b
14-3-3 g
14-3-3 ε
14-3-3 ζ
14-3-3 h
14-3-3 τ
14-3-3 s
++
+
++
+
-
++
++
++
+
++
+
-
++
++
++
+
++
-
-
++
++
Prominent
lack of expression
in peripheral mural granulosa
cells
14-3-3 b
14-3-3 g
14-3-3 ε
14-3-3 ζ
14-3-3 h
14-3-3 τ
14-3-3 s
Yes
Yes
Yes
No
Yes
Yes
Yes
Yes
No
No
No
No
No
No
Yes
Yes
Yes
No
No
Yes
Yes
Marked accumulation
in granulosa cells surrounding the antrum
14-3-3 b
14-3-3 g
14-3-3 ε
14-3-3 ζ
14-3-3 h
14-3-3 τ
14-3-3 s
Yes
Yes
No
No
No
No
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
’++’ = Considerable expression; ‘+’ = Some expression;
’-’ = Non-detectable expression; ‘Yes’ = Presence of the feature; ‘No’ = Feature not detectable
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extract was used as positive control. This is because all
isoforms of 14-3-3 have been indentified in brain except
14-3-3h which has been detected in skin [15]. Ovaries
from unprimed adult mice (2.5 months old), brain and
skin tissues were homogenized in a buffer containing
(10 mM Tris pH 7.0, 1 mM EDTA, 1 mM EGTA, 0.16%
benzamidine hydrochloride, 14 mM beta-mercaptoetha-
nol, 1 mM PMSF and 0.1 mM TPCK) pH 7.2, using a
mechanical homogenizer. The homogenized cell lysates
were then centrifuged at 16,000 μg for 30 min and the
Figure 12 Representative immunocytochemistry images of 14-3-3 protein isoforms along and in the zonae pellucidae of cumulus-free
oocytes isolated from ovaries of adult mice. The zona-intact cells were fixed in paraformaldehyde but not treated with detergent (see
Methods). Paired images of an oocyte (left image is brightfield and right is immunofluorescence) indicate staining along the zona and/or the cell
membrane for all isoforms except 14-3-3ζ. Note: the intent of this part of the study was not to examine the intracellular distribution of the
isoforms (see Figure 3 for those experiments) since the cells were not permeabilized to permit complete antibody penetration; however, cells
may be partially permeabilized by fixation accounting for the detection of intracellular proteins in some cells. (A,B) 14-3-3 b. (C,D) 14-3-3 g. (E,F)
14-3-3 ε. (G,H) 14-3-3 ζ. (I,J) 14-3-3 h. (K,L) 14-3-3 τ. (M,N) 14-3-3s. (O,P) Control image without primary antibody addition.
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supernatants containing the total soluble protein
extracts were used for SDS-PAGE and Western blotting.
We used the commercial rabbit anti-14-3-3 isoform
panel (PAN017) from AbD Serotec, for Western blotting
as well as immunocytochemical and immunohistochem-
ical staining (see below) of the different 14-3-3 isoforms
in mouse ovaries, oocytes and eggs. The immunogens,
against which the antibodies were raised, were synthetic
peptides corresponding to acetylated N-terminal
sequences of sheep 14-3-3 proteins. They are raised
against synthetic peptides corresponding to the follow-
ing acetylated N-terminal sequences of sheep 14-3-3 iso-
forms: 14-3-3b, TMDKSELVC; 14-3-3g,
VDREQLVQKAC; 14-3-3ε, MDDREDLVYQAKC; 14-3-
3ζ: MDKNELVQKAC; 14-3-3h, GDREQLLQRARC; 14-
3-3 τ, MEKTELIQKAC; 14-3-3s, MERASLIQKAC.
Two additional antibodies to 14-3-3b and 14-3-3ζ
were also used to confirm the presence of these iso-
forms (rabbit anti-14-3-3b, sc-628 and rabbit anti-14-3-
3 ζ sc-1019, Santa Cruz Biotechnology). All antibodies
were used at a dilution of 1:1,000 in blocking buffer (5%
milk in 1X TBS, 0.1% Tween-20). The secondary anti-
body for all experiments was HRP-conjugated goat anti-
rabbit (Genscript; 1 mg/ml stock) used at a dilution of
1:2,000 in the blocking buffer.
The relative abundance of each 14-3-3 isoform in
oocytes and eggs was determined in a semi-quantitative
manner. Proteins from 200 oocytes and 200 eggs were
separated by electrophoresis on the same gel, transferred
to membrane at the same time and immunoblotted
together under the same conditions using one of the six
14-3-3 antibodies. This procedure was repeated two
additional times with the same antibody. There will be
inherent differences in the intensities of bands for each
immunoblot processed, but for a given blot the intensity
of the egg band can be compared to the intensity of the
oocyte band. To summarize the three experiments for
each of the six isoforms, the band intensities for oocyte
and egg lanes in a given blot were analyzed using NIH
image and compared to each other. The intensity of the
oocyte band was normalized to 100% for each blot and
the egg intensity (reflecting the relative protein amount)
was then expressed as a percentage of the oocyte inten-
sity for each of the three blots analyzed for each iso-
form. Note that no comparison should be drawn for the
band intensities among the isoforms since the antibodies
detecting the isoforms were different from each other,
with possible differences in their affinities.
Immunocytochemistry of oocytes and eggs
Oocytes and eggs were fixed in freshly prepared 3.7%
paraformaldehyde for 30-60 min, washed in PBS-PVA
(PBS containing 1% PVA), permeabilized with 1% Triton
X-100 to promote antibody penetration, washed in PBS-
PVA, then treated with blocking buffer (5% normal goat
serum in PBS-PVA), and incubated overnight with each
of the primary antibodies for 14-3-3 isoforms (rabbit
anti-14-3-3 isoform panel PAN017, AbD Serotec; diluted
1:200 in 1% goat serum blocking buffer). Following
washing, the cells were incubated with Cy3-conjugated
goat anti-rabbit secondary antibody (Jackson ImmunoR-
esearch Laboratories) diluted 1:200 in blocking buffer
for several hours, washed again and transferred to an
anti-fade solution (SlowFade; Invitrogen). All cells were
imaged with the Olympus Fluoview FV500 confocal
microscopy system using a 60× oil immersion lens and
various confocal zooms; the scale bars on the images
indicate the final magnification. Images were captured
and examined at multiple confocal planes. The represen-
tative images shown here are primarily images at the
plane of the optical equator. For each isoform experi-
ment, 5-7 oocytes and 5-7 eggs were examined at the
same time under the same staining and imaging condi-
tions. The experiment was repeated twice for each
isoform.
In oocytes, the nucleus is readily discernible in fluor-
escence images or the corresponding brightfield images.
In eggs, the location of the condensed metaphase II
chromosomes can sometimes be determined by a bulge
at one pole of the egg or by the absence of fluorescence
causing an outline of the unlabeled chromosomes. In an
additional experiment using the 14-3-3h antibody, con-
densed meiotic chromosomes in eggs were identified by
staining with the DNA-staining Hoechst dye (0.001 mg/
ml) and imaged with conventional epifluorescence
microscopy (Figure 3N, inset). In several experiments,
eggs were simultaneously incubated in both the 14-3-3h
isoform antibody and an antibody to alpha-tubulin to
identify the meiotic spindle microtubules (rat anti-alpha
tubulin; sc-69970; 200 μg/ml diluted 1:200 in 1% block-
ing buffer; Santa Cruz Biotechnology). The secondary
antibody was FITC-conjugated goat anti-rat from (Jack-
son Laboratories) (diluted 1:200 in blocking buffer). In
all cases, control oocytes and eggs were incubated in
secondary antibody alone and imaged using the same
confocal settings as used for experimental, antibody-
labeled cells. Background fluorescence was minimal.
An additional set of immunofluorescence experiments
was performed to examine the presence of extracellular
14-3-3 isoforms associated with isolated oocytes. The
immunofluorescence method was used as described
above, but with several changes. In this case, the zonae
were not removed before fixation in 3.7% paraformalde-
hyde and the cells were not treated Triton X-100 to per-
meabilize the cell membranes following fixation. All
other staining procedures were the same. We wanted to
look at the possibility of secreted proteins in oocytes.
This experiment was not intended to examine the
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intracellular distribution of isoforms (see above methods
and Figure 3 for that experiment); however, we have
known for many years that mouse oocytes and eggs
sometimes are partially permeabilized on fixation alone
(no detergent added). Therefore some staining within
the oocytes may occur, but is not be a complete repre-
sentation since the permeability of cells may vary from
cell to cell and is not uniform within a cell.
Immunohistochemistry of tissue sections
Ovaries, brain and skin tissues were collected from
unprimed adult mice (2.5 months old) and fixed in 4%
paraformaldehyde in PBS overnight. They were then
dehydrated through a graded series of ethanol followed
by two changes of CitriSolv and embedded in paraffin.
Multiple microtome tissue sections of 6 μm thickness
were transferred to slides pre-coated with poly-L-
lysine. Following removal of paraffin and rehydration,
antigens were recovered by boiling the sections for 1
min, three times in Antigen Retrieval Citra solution
(#HK086-5K, Biogenex) with intermittent cooling. Tis-
sue sections were then cooled at room temperature for
30 min and then washed in deionised water for 5 min.
Endogenous peroxidase was blocked by incubation of
tissue sections in 0.3% hydrogen peroxide for 30 min.
Tissues were then incubated for 20 min in PBS block-
ing buffer or 0.15% normal goat serum (VectaStain
Elite ABC Kit, #PK-6101, Vector Laboratories). Tissues
sections were incubated overnight at 4°C in a humidi-
fied chamber with each of the different primary antibo-
dies (14-3-3 isoform panel PAN017, AbD Serotec, see
above) diluted in blocking buffer at dilutions recom-
mended by the manufacturer and a prior study
[34]:14-3-3b 1:600, 14-3-3g 1:800, 14-3-3ε 1:400, 14-3-
3ζ 1:400, 14-3-3h 1:3,200, 14-3-3τ 1:60, and 14-3-3s
1:100. The same dilutions were used for positive con-
trol sections. The rabbit serum used in matching nega-
tive control sections, were immunostained at a dilution
identical to that used in corresponding sample sections
for the isoforms.
Following antibody incubation, slides containing tissue
sections were washed in buffer (PBS, pH 7.5) for 5 min,
incubated for 30 min in biotinylated secondary antibody
(VectaStain Elite ABC Kit, Vector Laboratories) diluted
in blocking buffer and washed again in buffer for 5 min.
This was followed by incubation of the tissues for 30
min in VectaStain Elite ABC Reagent (prepared accord-
ing to the manufacturer’s instructions; Vector Labora-
tories). DAB substrate was prepared using Vector
Laboratories DAB peroxidase substrate Kit (SK-4100)
according to instructions specified in kit. Tissues were
treated with DAB substrate for 3-4 min until develop-
ment of optimum brown color, rinsed with tap water
and counter-stained with Hematoxylin.
The ABC-immunostaining method produces minimal
background staining. To examine the background
staining, two sets of negative controls were used. One
set of tissue sections was processed without the addi-
tion of primary antibodies. Since the primary antibo-
dies were rabbit polyconlonals, the other control set
utilized tissue sections incubated in normal rabbit
serum (Jackson ImmunoResearch) prior to incubation
with the secondary antibodies. In both cases, control
sections did not show brown staining, confirming spe-
cific localization by this method. Brain tissue sections
were used as positive control for all isoforms of 14-3-3
except 14-3-3s for which skin tissue was used as posi-
tive control (see Figure 13). This is because all iso-
forms of 14-3-3 have been identified in brain with the
exception of 14-3-3s [13]. Skin sections were used as
positive control for 14-3-3s since 14-3-3s is known to
be found in epidermis [15] (see Figure 13). For each
isoform, dilutions of primary antibodies or rabbit
serum for positive and negative controls were kept
identical. Each 14-3-3 isoform was studied individually
in a set of 3 separate stained ovarian tissue sections,
along with simultaneous staining of appropriate posi-
tive and negative controls. In addition the studies were
repeated on sections obtained from the ovary of a dif-
ferent unprimed adult mouse of the same age. The
characteristic features for all 14-3-3 isoforms, as identi-
fied by immunohistochemical staining, were examined
and tabulated (Table 1) independently by three indivi-
duals with agreement on the observations.
Figure 13 Representative control immunohistochemistry
images for the different 14-3-3 protein isoforms in tissue
sections. (A) Example of a positive control brain section obtained
for all 14-3-3 isoforms except for 14-3-3 s. (B) Skin positive control
for 14-3-3 s. (C) Example of a negative control section with no
primary antibody obtained for all isoforms. (D) Example of a
negative control with rabbit serum in place of primary antibody
obtained for all isoforms. All scale bars indicate 100 μm.
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